# ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion

> **NCT05225961** · PHASE4 · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 240 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Tirofiban
- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT05225961
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-20
- **Primary completion:** 2026-03-20
- **Final completion:** 2026-03-20
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05225961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05225961, "ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT05225961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*